A Case of Stage III c Ovarian Clear Cell Carcinoma: The Role for Predictive Biomarkers and Targeted Therapies

por Rahman, Munmun, Nakayama, Kentaro, Ishibashi, Tomoka, Ishikawa, Masako, Rahman, Mohammed Tanjimur, Katagiri, Hiroshi, Katagiri, Atsuko, Iida, Kouji, Kikuchi, Yoshihiro, Miyazaki, Kohji
Publicado 2013

CCNE1 amplification is associated with aggressive potential in endometrioid endometrial carcinomas

por NAKAYAMA, KENTARO, RAHMAN, MOHAMMED TANJIMUR, RAHMAN, MUNMUN, NAKAMURA, KOHEI, ISHIKAWA, MASAKO, KATAGIRI, HIROSHI, SATO, EMI, ISHIBASHI, TOMOKA, IIDA, KOUJI, ISHIKAWA, NORIYUKI, KYO, SATORU
Publicado 2015

KRAS and MAPK1 Gene Amplification in Type II Ovarian Carcinomas

por Rahman, Mohammed Tanjimur, Nakayama, Kentaro, Rahman, Munmun, Katagiri, Hiroshi, Katagiri, Atsuko, Ishibashi, Tomoka, Ishikawa, Masako, Sato, Emi, Iida, Kouji, Nakayama, Naomi, Ishikawa, Noriyuki, Miyazaki, Kohji
Publicado 2013

Nucleus accumbens-1/GADD45GIP1 axis mediates cisplatin resistance through cellular senescence in ovarian cancer

por Nakayama, Kentaro, Rahman, Munmun, Rahman, Mohammed Tanjimur, Nakamura, Kohei, Sato, Emi, Katagiri, Hiroshi, Ishibashi, Tomoka, Ishikawa, Masako, Iida, Kouji, Razia, Sultana, Ishikawa, Noriyuki, Kyo, Satoru
Publicado 2017